Scinai Immunotherapeutics Ltd. SCNI on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001611747
0001611747
EIN:
LEI:
(CF Office: 03 Life Sciences)
Business address:
JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, Israel, 00000
Phone: 972-8-9302529
JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, Israel, 00000
Phone: 972-8-9302529
Mailing address:
JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, Israel, 00000
JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, Israel, 00000
Category:
Former names:
- BiondVax Pharmaceuticals Ltd. - filings through 2023-08-28
Filings:
426 EDGAR filings since November 13, 2014
426 EDGAR filings since November 13, 2014
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 27, 2025 - 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16] Open documentClick to Open document FilingOpen filingClick to Open filing
- March 26, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- March 24, 2025 - 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16] Open documentClick to Open document FilingOpen filingClick to Open filing
- March 13, 2025 - 424B3: Prospectus [Rule 424(b)(3)] Open documentClick to Open document FilingOpen filingClick to Open filing
- March 12, 2025 - EFFECT: Notice of Effectiveness Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
No 8-K filing data for this company in last 110 days
[+] 10-K (annual reports) and 10-Q (quarterly reports)
No 10-K/10-Q filings for this company in last 365
days
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
No insider transaction filings for this company in last 365 days
- Beneficial ownership (Schedule 13D and 13G)
- March 26, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- March 4, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 24, 2025 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 426 entries
Data source:
CIK0001611747.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
